BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10334196)

  • 1. Combined mismatch and nucleotide excision repair defects in a human cell line: mismatch repair processes methylation but not UV- or ionizing radiation-induced DNA damage.
    O'Driscoll M; Martinelli S; Ciotta C; Karran P
    Carcinogenesis; 1999 May; 20(5):799-804. PubMed ID: 10334196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XPC lymphoblastoid cells defective in the hMutSalpha DNA mismatch repair complex exhibit normal sensitivity to UVC radiation and normal transcription-coupled excision repair of DNA cyclobutane pyrimidine dimers.
    Kobayashi K; O'Driscoll M; Macpherson P; Mullenders L; Vreeswijk M; Karran P
    DNA Repair (Amst); 2004 Jun; 3(6):649-57. PubMed ID: 15135732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mismatch repair and differential sensitivity of mouse and human cells to methylating agents.
    Humbert O; Fiumicino S; Aquilina G; Branch P; Oda S; Zijno A; Karran P; Bignami M
    Carcinogenesis; 1999 Feb; 20(2):205-14. PubMed ID: 10069455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cells bearing homozygous mutations in the DNA mismatch repair genes hMLH1 or hMSH2 are fully proficient in transcription-coupled nucleotide excision repair.
    Rochette PJ; Bastien N; McKay BC; Therrien JP; Drobetsky EA; Drouin R
    Oncogene; 2002 Aug; 21(37):5743-52. PubMed ID: 12173044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mismatch repair, G(2)/M cell cycle arrest and lethality after DNA damage.
    Aquilina G; Crescenzi M; Bignami M
    Carcinogenesis; 1999 Dec; 20(12):2317-26. PubMed ID: 10590226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of an involvement of the human mismatch repair genes hMLH1 and hMSH2 in nucleotide excision repair is dependent on UVC fluence to cells.
    Lee DF; Drouin R; Pitsikas P; Rainbow AJ
    Cancer Res; 2004 Jun; 64(11):3865-70. PubMed ID: 15172995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential involvement of the human mismatch repair proteins, hMLH1 and hMSH2, in transcription-coupled repair.
    Leadon SA; Avrutskaya AV
    Cancer Res; 1997 Sep; 57(17):3784-91. PubMed ID: 9288788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of the mismatch repair gene hMSH2 and hMSH6 in a human T-cell leukemia line tolerant to methylating agents.
    Levati L; Marra G; Lettieri T; D'Atri S; Vernole P; Tentori L; Lacal PM; Pagani E; Bonmassar E; Jiricny J; Graziani G
    Genes Chromosomes Cancer; 1998 Oct; 23(2):159-66. PubMed ID: 9739019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines.
    Branch P; Hampson R; Karran P
    Cancer Res; 1995 Jun; 55(11):2304-9. PubMed ID: 7757980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mismatch repair and DNA damage signalling.
    Stojic L; Brun R; Jiricny J
    DNA Repair (Amst); 2004; 3(8-9):1091-101. PubMed ID: 15279797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mismatch repair provokes chromosome aberrations in hamster cells treated with methylating agents or 6-thioguanine, but not with ethylating agents.
    Armstrong MJ; Galloway SM
    Mutat Res; 1997 Feb; 373(2):167-78. PubMed ID: 9042397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced host cell reactivation of oxidative DNA damage in human cells deficient in the mismatch repair gene hMSH2.
    Pitsikas P; Lee D; Rainbow AJ
    Mutagenesis; 2007 May; 22(3):235-43. PubMed ID: 17351251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation.
    Yan T; Schupp JE; Hwang HS; Wagner MW; Berry SE; Strickfaden S; Veigl ML; Sedwick WD; Boothman DA; Kinsella TJ
    Cancer Res; 2001 Nov; 61(22):8290-7. PubMed ID: 11719462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of DNA mismatch repair in the cytotoxicity of ionizing radiation.
    Fritzell JA; Narayanan L; Baker SM; Bronner CE; Andrew SE; Prolla TA; Bradley A; Jirik FR; Liskay RM; Glazer PM
    Cancer Res; 1997 Nov; 57(22):5143-7. PubMed ID: 9371516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased UV sensitivity, mismatch repair activity and abnormal cell cycle checkpoints in skin cancer cell lines derived from UVB-irradiated XPA-deficient mice.
    Ichikawa M; Nakane H; Marra G; Corti C; Jiricny J; Fitch M; Ford JM; Ikejima M; Shimada T; Yoshino M; Takeuchi S; Nakatsu Y; Tanaka K
    Mutat Res; 2000 May; 459(4):285-98. PubMed ID: 10844242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
    Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
    Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA mismatch repair deficiency stimulates N-ethyl-N-nitrosourea-induced mutagenesis and lymphomagenesis.
    Claij N; van der Wal A; Dekker M; Jansen L; te Riele H
    Cancer Res; 2003 May; 63(9):2062-6. PubMed ID: 12727820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity.
    Cortellino S; Turner D; Masciullo V; Schepis F; Albino D; Daniel R; Skalka AM; Meropol NJ; Alberti C; Larue L; Bellacosa A
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15071-6. PubMed ID: 14614141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
    Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.